Al-Habet S, Rogers H J
Br J Clin Pharmacol. 1980 Nov;10(5):503-8. doi: 10.1111/j.1365-2125.1980.tb01796.x.
1 Doses of 16, 32, 48 and 64 mg prednisolone were administered intravenously to normal volunteers who also received 100 prednisolone orally. Plasma prednisolone concentrations were estimated by quantitative thin layer chromatography. 2 The bioavailability fraction was 1.063 +/- 0.154 (s.d.) indicating complete availability of prednisolone following oral administration. 3 The mean T 1/2 over all doses were 4.11 +/- 0.97 (s.d.) h and there was no evidence of a dose-related change in its value. 4 The mean systemic clearance over all doses was 0.104 +/- 0.034 (s.d) 1 h-1 kg-1. There was no evidence of a dose-related change in clearance or in the apparent volume of distribution (overall mean 0.588 +/- 0.152 1 kg-1). 5 The area under the plasma concentration-time curve was linearly related to dose. 6 Plasma concentration-time curves normalised for dose were superimposable. 7 It was concluded that over the dose range investigated, non-linear pharmacokinetic behaviour had not been demonstrated in this group of normal volunteers.
给正常志愿者静脉注射16毫克、32毫克、48毫克和64毫克的泼尼松龙,这些志愿者还口服了100毫克泼尼松龙。通过定量薄层色谱法估算血浆泼尼松龙浓度。
生物利用度分数为1.063±0.154(标准差),表明口服后泼尼松龙完全可用。
所有剂量的平均半衰期为4.11±0.97(标准差)小时,且无证据表明其值存在剂量相关变化。
所有剂量的平均全身清除率为0.104±0.034(标准差)升·小时⁻¹·千克⁻¹。没有证据表明清除率或表观分布容积存在剂量相关变化(总体平均值为0.588±0.152升·千克⁻¹)。
血浆浓度-时间曲线下面积与剂量呈线性相关。
按剂量归一化的血浆浓度-时间曲线可叠加。
得出结论,在所研究的剂量范围内,该组正常志愿者未表现出非线性药代动力学行为。